GDC-0994

DRUG2 trials

Sponsors

Genentech, Inc.

Conditions

Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, MelanomaSolid Tumor

Phase 1

A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors

CompletedNCT01875705

Genentech, Inc.Solid Tumor

Start: 2013-06-21End: 2016-09-23Updated: 2018-04-06

A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors

CompletedNCT02457793

Genentech, Inc.Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, Melanoma

Start: 2015-06-16End: 2016-12-05Updated: 2018-11-20